NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Food & Drug Law Weekly


Susan Hasty, Publisher
Table of Contents . . . April 10th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Food & Drug Law Weekly | Other Publications

Advocates for Youth - Advocates for Youth Applauds Court Ruling on EC Age Restriction

Americans United for Life (AUL) - Americans United for Life Condemns Ruling Increasing Minors' Access to Dangerous Plan B

Arcot Systems, Inc. - Arcot Digital Signature Solution Certified Compliant with SAFE-BioPharma Digital Standard™

Biopharmaceuticals - GPhA Statement on the Introduction of the Bipartisan Senate Biogenerics Consensus Bill: 'Promoting Innovation and Access to Life-Saving Medicine Act'

Cancer - Ezetimibe and Ezetimibe/Simvastatin Combo Pose No Increased Cancer Risk, Study Shows

Clinical Trial Research - Coast IRB Tells Congressional Committee Sting Operation Was Illegal, Unnecessarily Harmful

Food Poisoning - GAO Study Links Duty Circumvention with Evasion of Food Safety Laws

Impax Laboratories, Inc. - Impax Confirms Patent Lawsuit Relating to Doryx® Tablets 150 mg

InSync Software, Inc. - InSync Software Collaborates With IBM to Improve Food Safety

Mental Health - Studies from J. Sohel et al provide new data on mental health

Pharmaceuticals - The Dangers of Faking it

Reproductive Health - Federal Court Rules FDA Must Reconsider Plan B Decision

Reproductive Health - U.S. District Court Finds the FDA's Actions on Plan B(R) Tainted by Politics

Revolution Medical Corporation - Revolutions Medical Corporation New Corporate Headquarters

Sidley Austin LLP - BTI Consulting Group Names Eight Sidley Partners to 2009 Client Service All-Star Team

Abbott Furnace Company - Abbott Furnace Company Ships Munition Treatment Unit

Advaxis, Incorporated - Advaxis Updates Phase I Trial Survival Data: 23% of Patients Still Surviving after 2+ Years

Allos Therapeutics, Inc. - Allos Therapeutics Submits New Drug Application for Pralatrexate for Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

Alnara Pharmaceuticals - Alnara Pharmaceuticals Licenses Worldwide Rights to Liprotamase from Cystic Fibrosis Foundation

American Phytopathological Society - Plant pathologists call for more data to support pre-harvest food safety interventions

Anesthesia - Research findings from C.F. Wang et al update understanding of anesthesia

Antares Pharma, Inc. - Antares Pharma Reports Fourth Quarter and Year End 2008 Financial and Operating Results

Anthrax - Study results from E.J. Duncan and colleagues update understanding of anthrax

Atrial Fibrillation - Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, the Largest Atrial Fibrillation Outcomes Trial To Date

Autism - Curemark Receives Investigational New Drug Clearance for CM-AT for Autism

BioMedReports.com - FDA Calendar, Unbiased Reporting on Emerging Biotech Sector Now Available at BioMedReports.com

Bioterrorism - Researchers from Department of Agriculture publish findings in biochemistry

Bioterrorism - Studies from University of Pittsburgh, Medical Department have provided new information about bioterrorism

Bone Fractures - NovaLign(TM) Orthopaedics, Inc. Announces its First 510(K) Clearance From the FDA for New Intramedullary Fixation System

Bone Research - Hip Resurfacing Championed as a Bone-Preserving Alternative to Total Hip Replacement

Camstar Systems, Inc. - New Research Results Show Impact of Quality Systems in Life Sciences

Cancer - Findings from University of Southern Denmark, National Institute of Public Health advance knowledge in cancer

Cancer - IROs Help Decide Medically on Approved Uses of Off-Label Drugs for Cancer

Cancer - Statement of the American Cancer Society Cancer Action Network, American Heart Association, American Lung Association and the Campaign for Tobacco-Free Kids

Cancer Vaccines - ImQuest Presentations at Keystone Symposium Focus on Advancements in Their Therapeutic and Microbicide Development Programs

Cancer Vaccines - Research from W.W. Wang and co-researchers in the area of cancer vaccines published

CardiacAssist Inc. - CardiacAssist Introduces Longer Cannula Set for Its TandemHeart® System

Cardiology - Digirad Receives 510(k) for Cardius X-ACT Rapid Cardiac SPECT/VCT Imager

Cell Therapy - Scientists at Medical College of Georgia, Medical College report research in cell therapy

Cellumen, Inc. - Cellumen Appoints Dr. Jack A. Reynolds to Board of Directors

Celsion Corporation - Celsion Receives Orphan Drug Designation for ThermoDox® to Treat Primary Liver Cancer

Chagas Disease - New Chagas disease findings from University of Buenos Aires published

China Medicine Corporation - China Medicine Announces Record Fourth Quarter and 2008 Results

Clinical Trial Research - Atritech Completes $30 Million Financing

Clinical Trial Research - Neuromed Announces Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial

Crimson Life Sciences - Medical Device Labeling Survey by Crimson Life Sciences Exposes Serious Translation Risks

Depression - FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression

Depression - Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents

Endometriosis - Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain

Escherichia Coli - Data on Escherichia coli published by researchers at Department of Agriculture

Experimental Pain Therapy - Researchers at University of Southern Denmark, Institute of Public Health target experimental pain therapy

Generics - Mylan Confirms Four First-to-File Challenges

GlycoMimetics, Inc. GMI - GlycoMimetics, Inc. Completes Phase 1 Clinical Studies of Lead Drug Candidate

Haemorrhagic Fever With Renal Syndrome Genetics - New haemorrhagic fever with renal syndrome genetics research reported from Harbin Medical University, Department of Infectious Disease

Hard to Treat Diseases - HARD TO TREAT DISEASES HTDS Granted Registration and Licensing Approval By Vietnam FDA

Heart Disease - Siemens Highlights Cardiac-Specific C-Reactive Protein (hsCRP) Test at ACC 2009

Hyperuricemia Therapy - Recent findings from Veterans Affairs Medical Center, Department of Rheumatology highlight research in hyperuricemia therapy

JAMA and Archives Journals - Smokers may have increased risk of pancreatitis

Kidneys - New kidneys study findings have been published by scientists at Food & Drug Administration

Kureczka/Martin Associates - Data suggesting that omacetaxine can eradicate leukemic stem cells may offer a breakthrough for CML

La Torre Communications - Award-Winning Public Relations Expert April L. Hutcheson Joins La Torre Communications

Legionnaire Disease - Research from M.R.S. Ferre and co-authors reveals new findings on legionnaire disease

Life Sciences - Data on life sciences discussed by I.F. Khudair and colleagues

Life Sciences - Data on life sciences published by researchers at Osaka City Institute of Public Health and Environmental Science

Life Sciences - New life sciences study findings have been reported by researchers at Northwestern University, Department of Microbiology-Immunology

Life Sciences - New life sciences study findings have been reported by researchers at University of California

Life Sciences - Recent studies by R.R. Ratan and co-authors add new data to life sciences findings

Life Sciences - Report summarizes life sciences study findings from University of Pittsburgh

Life Sciences - Researchers from National Institute of Health and Nutrition report recent findings in life sciences

Life Sciences - Scientists at Marshall University publish new data on life sciences in children

McMaster University - TB vaccine developed at McMaster University in Canada

Medgenics - Medgenics' Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients

Mobile Aspects, Inc. - University of Michigan Health System Implements Tissue Tracking Solution from Mobile Aspects

Multiple Sclerosis - Epiphany Biosciences Initiates Program to Assess Valomaciclovir (EPB-348) as Adjunctive Therapy in Multiple Sclerosis (MS)

Neurotech Pharmaceuticals, Inc. - Positive Results from Neurotech’s NT-501 Phase 2 Dry AMD Geographic Atrophy Study Demonstrate Proof of Concept

Noven Pharmaceuticals, Inc. - Noven Provides Update on Daytrana® Methylphenidate Transdermal System

On-X Life Technologies, Inc. - On-X Life Technologies Doubles Manufacturing Space in Austin

Oregon State University - New wheat disease could spread faster than expected

Ortho-McNeil-Janssen Pharmaceuticals Inc. - FDA Advisory Committee Finds Favorable Risk-Benefit Profile for Oral Anticoagulant Rivaroxaban for Prophylaxis of Deep Vein Thrombosis and Pulmonary Embolism After Hip or Knee Replacement Surgery

Ovarian Cancer - Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer

Pharmaceuticals - Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection

Prostate Cancer - Columbus Children's Hospital publishes research in prostate cancer

Public Health - Crossflo Provides Data Sharing for Montana Health Information Exchange

RAND Corporation - Study finds program has improved health agencies' preparedness for bioterror and disease outbreaks

Regulatory Actions - Research from J.P. Myers and co-researchers in the area of regulatory actions described

Research and Markets - Analysis of AERS Data on Anti-Diabetics Provides a Detailed Analysis on the Adverse Events Reported in the FDA AERS Database

Research and Markets - The Bactericidal and Oligodynamic Action of Silver and Copper in Hygiene, Medicine and Water Treatment

Rexahn Pharmaceuticals, Inc. - Rexahn Pharmaceuticals, Inc. RNN Initiates Phase II Pancreatic Cancer Clinical Trial

Spectrum Pharmaceuticals, Inc. - Spectrum Pharmaceuticals Announces That FDA Has Accepted FUSILEV™ sNDA for Colorectal Cancer Indication

Stanford University Medical Center - Stanford Cancer Expert Ronald Levy Will Receive King Faisal Prize in Medicine March 29

Teva Pharmaceutical Industries Ltd. - Teva Announces FDA Response to Citizen Petition

Therakos, Inc. - U.S. FDA Approves New THERAKOS(TM) CELLEX(TM) Photopheresis System

Transfusion Medicine - Findings from St. James's University, Institute of Oncology provide new insights into transfusion medicine

Transient Ischemic Attack - Reports from C. Winward et al highlight recent research in transient ischemic attack

Tuberculosis - Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients

Vaccines - Hard to Treat Diseases (HTDS) enters Guatemala market

W. L. Gore & Associates - Gore Receives FDA Approval for Larger Diameter, Small Profile AAA Endoprosthesis

West Nile Virus - Research in the area of west nile virus reported from G. Zou and colleagues

YourBloodPressureStudy.com - The Patient Recruiting AgencyTM Announces a Series of New Blood Pressure Studies



Return to Top of Page

-----------------------
PR Login